Table 1 Studies on pharmacoeconomics of subcutaneous immunotherapy
Author (year) | Patients | Allergen | Study duration (years) | Results |
|---|---|---|---|---|
Buchner (1995) [16] | Adults | Pollen, mites | 10 | −54% costs for symptomatic treatment |
Schadlich (2000) [17] | Adults | Pollen, mites | 10 | €332-608 saving per patient |
Petersen (2005) [18] | Adults | Pollen | 4 | €203 saving per patient |
Ariano (2006) [19] | Adults | Pollen | 6 | 48% money saving at year 4 |
Omnes (2007) [20] | Adults & children | Pollen, mites | 6 | €1327 saving per patient for pollen, €393 for mites |
Hankin (2008) [21] | Children | Pollen, mites | 1.5 | €308 6-month saving per patient |
Hankin (2010) [22] | Children | Pollen, mites | 1.5 | −34% total healthcare cost per patient |
Wang (2011) [23] | Adults | Pollen, mites | 1.5 | −41% total healthcare cost per patient |